Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 2
A Phase 2 Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Silevertinib, an Oral EGFR Inhibitor, in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter and EGFRvIII
The purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) b…
Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more
Estimated
~$10 – $8,750
Black Diamond Therapeutics, Inc.NCT07326566
Phase 1
Dosimetry and Bio-distribution of 203Pb-RMX-VH-PIB in Newly Diagnosed or Recurrent Patients With Solid Tumors: A Phase I Exploratory Study
The goal of this Phase I clinical trial is to evaluate how the imaging drug 203Pb- RMX-VH-PIB distributes in the body and how much radiation different organs r…
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
Estimated
~$10 – $8,750
Radiomedix, Inc.NCT07733674
Phase 1
Phase I/II Study of Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed Glioblastoma (GBM)
The purpose of this study is to evaluate the safety and efficacy of administering the medication capecitabine along with temozolomide when you start your month…
Glioblastoma Multiforme (GBM)GlioblastomaGlioma of Brain+6 more
Estimated
~$10 – $7,500
Northwell HealthNCT03213002